5-氧代-2-吡咯烷乙酸 | 64520-53-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 5-氧代-2-吡咯烷乙酸
• 英文名称: (5-oxo-pyrrolidin-2-yl)-acetic acid
• 英文别名: (5-Oxo-pyrrolidin-2-yl)-essigsaeure；2-oxo-5-pyrrolidinyl acetic acid；5-oxo-2-pyrrolidineacetic acid；2-pyrrolidinone-5-acetic acid；2-(5-Oxopyrrolidin-2-yl)acetic acid
• CAS: 64520-53-2
• 化学式: C₆H₉NO₃
• mdl: MFCD09040737
• 分子量: 143.142
• InChiKey: LRKCFWRBMYJRIK-UHFFFAOYSA-N

物化性质

• 熔点：
  120.5-122.2 °C
• 沸点：
  446.1±18.0 °C(Predicted)
• 密度：
  1.261±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.666
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2933790090

反应信息

• 作为反应物：
  描述：

  5-氧代-2-吡咯烷乙酸 在 叠氮磷酸二苯酯 、 三乙胺 作用下， 以 甲苯 为溶剂， 反应 20.0h， 以47.7%的产率得到(+/-)-2-azarolziracetam
  参考文献：
  名称：

  Synthesis of 2-Oxa and 2-Aza Analogs of Pyrrolizidine-3,5-diones (Lukes-Sorm Dilactam)

  摘要：

  The synthesis of 2-oxa and 2-aza analogs of pyrrolizidine-3,5-dione (Lukes-Sorm dilactam), which has amnesia reversal activity, is reported. Optically active (+)-2-oxa and (+)-2-aza analogs [(+)-2 and (+)-3] and racemic 2-aza analog and its 1-methoxycarbonyl derivatives [(+)-3 and (+)-13 and -14] were prepared from (-)-S-pyroglutamic acid and succinimide, respectively.

  DOI：

  10.3987/com-91-s56
• 作为产物：
  描述：

  (E)-己-3-烯二腈 在 盐酸 、 甲醇 、 氨 作用下， 生成 5-氧代-2-吡咯烷乙酸
  参考文献：
  名称：

  Synthesis of Ecgoninic Acid and Related Pyrrolidones

  摘要：

  DOI：

  10.1021/ja01162a104

文献信息

• PROCESS FOR THE SYNTHESIS OF SUBSTITUTED GAMMA LACTAMS
  申请人：Allergan, Inc.

  公开号：US20140058117A1

  公开（公告）日：2014-02-27

  The present invention provides synthetic processes for the preparation of a variety of well-defined substituted gamma lactams. The compounds that can be prepared by the process of the invention are useful for treating a variety of conditions. In some embodiments of the invention, the compounds are useful for treating ocular disorders, such as, for example, glaucoma, lowering of elevated intraocular pressure, and the like. In other embodiments, the compounds are useful for treating irritable bowel disease. In further embodiments, the compounds are useful in promoting hair growth. In still further embodiments, the compounds are useful in promoting wound healing, scar reduction, and the like.

  本发明提供了一种用于制备多种定义明确的取代γ-内酰胺的合成过程。可以通过本发明的过程制备的化合物可用于治疗多种疾病。在某些发明的实施例中，这些化合物用于治疗眼部疾病，例如青光眼、降低升高的眼内压等。在其他实施例中，这些化合物用于治疗肠易激综合症。在更进一步的实施例中，这些化合物用于促进毛发生长。在更进一步的实施例中，这些化合物用于促进伤口愈合、减少疤痕等。
• Thrombin inhibitors
  申请人：Eli Lilly and Company

  公开号：US06391901B1

  公开（公告）日：2002-05-21

  This application relates to novel compounds of formula I (and their pharmaceutically acceptable salts), as defined herein, processes and intermediates for their preparation, pharmaceutical formulations comprising the novel compounds of formula I, and the use of defined compounds of formula I as thrombin inhibitors.

  这项申请涉及到式I的新化合物（及其药学上可接受的盐），如本文所定义，用于它们的制备的过程和中间体，包含式I的新化合物的药物配方，以及将式I的特定化合物用作凝血酶抑制剂。
• [EN] COMPOUNDS FOR TREATMENT OF CANCER AND EPIGENETICS<br/>[FR] COMPOSÉS DESTINÉS AU TRAITEMENT DU CANCER ET ÉPIGÉNÉTIQUE
  申请人：AGENCY SCIENCE TECH & RES

  公开号：WO2017061957A1

  公开（公告）日：2017-04-13

  Compounds For Inhibition Of Cancer and Epigenesis The present invention relates to quinolines and 5,6,7,8-tetrahydroacridines of the formula (I) wherein Z1, Z2, X, R1 to R8 and Y are defined as described in the specification, or a pharmaceutically acceptable form or prodrug thereof, that are inhibitors of methyl transferases such as protein lysine methyltransferases and more particularly SMYD3. The present invention also relates to the methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of disorders/conditions/diseases involving, relating to or associated with enzymes having methyl transferase activities/functions and/or via unspecified/multi-targeted mechanisms.

  抑制癌症和表观遗传学的化合物。本发明涉及式(I)的喹啉和5,6,7,8-四氢喹啉，其中Z1、Z2、X、R1至R8和Y的定义如说明书中所述，或其药学上可接受的形式或前药，它们是甲基转移酶的抑制剂，如蛋白赖氨酸甲基转移酶，特别是SMYD3。本发明还涉及它们的制备方法，含有这些化合物的药物组合物，以及这些化合物在治疗涉及、与或与具有甲基转移酶活性/功能的酶或通过未指定/多靶向机制相关的紊乱/疾病/疾病的用途。
• [EN] NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE<br/>[FR] NOUVEAUX LACTAMES FONCTIONNALISÉS COMME MODULATEURS DU RÉCEPTEUR 7 DE LA 5-HYDROXYTRYPTAMINE, ET PROCÉDÉ POUR LEUR UTILISATION
  申请人：UNIV TEMPLE

  公开号：WO2021097116A1

  公开（公告）日：2021-05-20

  Described herein are new, selective modulators of the 5 -HT7 receptor. These selective compounds can be useful for the treatment of CNS and non-CNS indications. Compounds described herein can be selective in targeting 5-HT7 receptors as compared to other receptors and/or by selective targeting 5-HT7 receptors expressed in certain tissues or organs, thereby effective selectivity through a particular partitioning profile of the 5- HT7 modulator.

  本文描述了5-HT7受体的新型选择性调节剂。这些选择性化合物可以用于治疗中枢神经系统和非中枢神经系统的适应症。本文描述的化合物可以在靶向5-HT7受体方面具有选择性，相对于其他受体或通过选择性靶向在某些组织或器官中表达的5-HT7受体而言，从而通过5-HT7调节剂的特定分区配置实现有效选择性。
• Polarizing plate protective film, polarizing plate and liquid crystal display device
  申请人：Murakami Takashi

  公开号：US20080049324A1

  公开（公告）日：2008-02-28

  A polarizing plate protective film comprising a cellulose ester, and a saccharide ester compound in which all or a part of OH groups in Compound (A) or in Compound (B) are esterified, wherein Compound (A) consists of one of a furanose structure and a pyranose structure, and Compound (B) consists of two to twelve of at least one type of a furanose structure and a pyranose structure which are bonded in Compound (B); wherein the polarizing plate protective film exhibits Ro of 0-10 nm and Rt of −30 to +20 nm.

  一种极化片保护膜，包括纤维素酯和一种糖酯化合物，其中化合物（A）或化合物（B）中的全部或部分OH基团被酯化，化合物（A）由呋喃糖或吡喃糖结构中的一种组成，化合物（B）由化合物（B）中至少一种呋喃糖或吡喃糖结构的两到十二个组成，这些结构在化合物（B）中被结合；其中，极化片保护膜的Ro值为0-10 nm，Rt值为-30到+20 nm。